IEB Symposium
The Inner Ear in Translational Research
Closing the gap toward causal treatment
29. September 2012
I. Endogene causes of hearing loss
Dirk Kunst, University Medical Centre St. Radboud, Nijmegen, The Netherlands
Genotype-phenotype correlations in non-syndromic hearing loss
Hannie Kremer, University Medical Centre St. Radboud, Nijmegen, The Netherlands
Causative genes involved in nonsyndromic sensorineural hearing loss
Saskia Biskup, CeGaT GmbH, Tübingen, Germany
Next-generation sequencing for genome-wide genotyping allowing for diagnosis of new deafness genes
II. Exogene causes of hearing loss
Edwin Rubel, Washington University, Seattle, USA
Drug development through in vivo high-throughput screening: Genetic and pharmacological modulation of hair cell toxicity
Jonathan Gale, University College London Ear Institute, London, UK
Sensory hair cell death and protection
III. Screening and stem cell technologies
Marcelo N. Rivolta, University of Sheffield, Sheffield, UK
Stem cells for potential future treatment options for hearing disorders
Albert Edge, Harvard Medical School, Boston, USA
Cell-based assays using screening technologies in the search for new drugs
IV. Drug delivery to the inner ear
Alec N. Salt, Washington University School of Medicine, St. Louis, USA
Manipulations of the cochlea and measurement of functional status
Takayuki Nakagawa, Kyoto University, Kyoto, Japan
Intracochlear drug delivery systems and new therapeutic concepts